Thalassemia is considered the most common genetic disorder worldwide. In Europe the disease is particularly prevalent in inhabitants of Italy and Greece. It is also common in South East Asia and in the Middle East, where it represents an important economic and social burden. In North America more than 800 patients are included in the Registry of the National Institutes of Health-sponsored Thalassemia Clinical Research Network.1 Thalassemia major used to be a rapidly fatal disease and the results obtained in terms of survival have been striking in the more industrialized parts of the world, while they remain disappointing in lowincome countries. In this issue of the journal there is one article reporting the results, in terms of survival, in the Greek Cypriot population,2 and two articles evaluating new approaches to the therapy of thalassemia.
Thalassemia. A few new tiles in a large mosaic.
BORGNA, Caterina
2006
Abstract
Thalassemia is considered the most common genetic disorder worldwide. In Europe the disease is particularly prevalent in inhabitants of Italy and Greece. It is also common in South East Asia and in the Middle East, where it represents an important economic and social burden. In North America more than 800 patients are included in the Registry of the National Institutes of Health-sponsored Thalassemia Clinical Research Network.1 Thalassemia major used to be a rapidly fatal disease and the results obtained in terms of survival have been striking in the more industrialized parts of the world, while they remain disappointing in lowincome countries. In this issue of the journal there is one article reporting the results, in terms of survival, in the Greek Cypriot population,2 and two articles evaluating new approaches to the therapy of thalassemia.I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
